Company Name or Ticker Symbol
Search for other Categories

Cellect Biotechnology Ltd.  (APOP)
Other Ticker:  
    Sector  Healthcare    Industry Biotechnology & Drugs
   Industry Biotechnology & Drugs
   Sector  Healthcare

Cumulative Cellect Biotechnology Ltd.'s Quick Ratio for Trailing Twelve Months Period

APOP's Quick Ratio for Trailing Twelve Months Period and Cash & cash equivalent, Current Liabilities growth

APOP Quick Ratio for Trailing Twelve Months Period

(Dec 31 2018)
IV. Quarter
III. Quarter
(Jun 30 2018)
II. Quarter
I. Quarter
(Dec 31 2017)
IV. Quarter
Y / Y Current Liabilities Growth - - - - -
Y / Y Cash & cash equivalent Growth - - - - -
Quick Ratio for Trailing Twelve Months Period 3.81 3.89 4.11 3.64 -
Total Ranking # 650 # # # #
Seq. Current Liabilities Growth 0 % 496.71 % -83.24 % - -
Seq. Cash & cash equivalent Growth 0 % 212.11 % -67.96 % - -

Quick Ratio for Trailing Twelve Months Period Comment
On the trailing twelve months basis Due to unchange in Current Liabilities in the IV. Quarter to $5 millions, average cumulative Quick Ratio for Trailing Twelve Months Period decreased to 3.81 below Cellect Biotechnology Ltd. average Quick Ratio for Trailing Twelve Months Period.
Quick Ratio for Trailing Twelve Months Period is the average cumulative value over the last four quarters.

Among companies operatig within Biotechnology & Drugs industry 100 other companies have achieved higher Quick Ratio for Trailing Twelve Months Period than Cellect Biotechnology Ltd.. While Quick Ratio for Trailing Twelve Months Period total ranking has deteriorated compare to previous quarter from to 650.

What is Quick Ratio?
Learn more about APOP
Quick Ratio APOP in the most recent quarter
Quick Ratio for Trailing Twelve Months Period Company Ranking
Within: No.
Industry # 101
Sector # 316
S&P 500 # 643

Quick Ratio for Trailing Twelve Months Period Statistics
High Average Low
3.64 3.64 3.64
(Dec 31 2018)  

Companies with similar average Quick Ratio for Trailing Twelve Months Period for 12 months ending Dec 31 2018, within Biotechnology & Drugs Industry Quick Ratio for Trailing Twelve Months Period
Armo Biosciences, Inc.  10.40 
Intellia Therapeutics, Inc.  10.34 
Aerpio Pharmaceuticals, Inc.  10.14 
Assembly Biosciences, Inc.  9.99 
Gritstone Oncology, Inc.  9.81 
Dare Bioscience, Inc.  9.72 
Cellectis S.a.  9.63 
Spark Therapeutics, Inc.  9.36 
Idera Pharmaceuticals, Inc.  9.04 
Cellular Biomedicine Group, Inc.  8.95 
Proteostasis Therapeutics, Inc.  8.70 
Sesen Bio, Inc.  8.54 
Urogen Pharma Ltd.  8.53 
Momenta Pharmaceuticals Inc  8.13 
Soleno Therapeutics Inc  8.11 
Capricor Therapeutics, Inc.  8.11 
Myokardia Inc  8.05 
Vical Inc  7.94 
Aclaris Therapeutics, Inc.  7.87 
Foamix Pharmaceuticals Ltd.  7.69 
Diffusion Pharmaceuticals Inc.  7.52 
Aerie Pharmaceuticals Inc  7.51 
Fate Therapeutics Inc  7.30 
Wave Life Sciences Ltd.  7.29 
Vistagen Therapeutics, Inc.  7.12 
La Jolla Pharmaceutical Co  7.00 
Neuronetics, Inc.  6.98 
Caladrius Biosciences, Inc.  6.94 
Arca Biopharma, Inc.  6.93 
Infinity Pharmaceuticals, Inc.  6.88 


Advance Monthly Sales

Consumer Price Index CPI

Producer Price Index PPI

Retail Inventories

Personal Income

Gross Domestic Product GDP

Money Supply

Industrial Production


Employment Situation

US International Trade

Factory Orders

Durable Goods

Construction Spending

Housing Starts

Vehicle Unit Sales


Event Calendar

MAGS's Profile

Stock Price

MAGS's Financials

Business Description


Charts & Quotes

MAGS's News


MAGS's Competitors

Customers & Markets

Economic Indicators

MAGS's Growth

Company Segments


Stock Performance

Growth Rates




Financial Strength


Largest Companies

Management Effectivness


At a Glance


Growth Rates



Financial Strength


At a Glance



Sectors & Industries





At a Glance








About us


Financial Terms

Technical Analysis

Fundamental Analysis

Energy Terms

Manufacturing Terms

Transportation Terms

Health Care

Insurance Terms

Economy Terms

Hotel & Leisure Terms

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.  Free Stock Market News Feeds
   Copyright © 2019 CSIMarket, Inc. All rights reserved. This site uses cookies to make your browsing experince better. By using this site, you agree to the Terms of Service and Privacy Policy - UPDATED (Read about our Privacy Policy)

Intraday Data provided by Barchart and subject to terms of use. To view Intraday Stock Data Java must be installed. Java content may be prohibited by the security software, to see the stock quotes, choose "allow content from this page" option. Stock Price, historical and current end-of-day data provided by eoddata. Intraday data delayed per exchange requirements. S&P/Dow Jones Indices (SM) from Barchart and Eoddata. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com
CSIMarket.com 1500 N. University Drive, Coral Springs, FL 33071